PDGF-BB and IL-4 co-overexpression is a potential strategy to enhance mesenchymal stem cell-based bone regeneration

BACKGROUND: Mesenchymal stem cell (MSC)-based therapy has the potential for immunomodulation and enhancement of tissue regeneration. Genetically modified MSCs that over-express specific cytokines, growth factors, or chemokines have shown great promise in pre-clinical studies. In this regard, the ant...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cell Res Ther
Autors principals: Zhang, Ning, Lo, Chi-Wen, Utsunomiya, Takeshi, Maruyama, Masahiro, Huang, Ejun, Rhee, Claire, Gao, Qi, Yao, Zhenyu, Goodman, Stuart B.
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2021
Matèries:
Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7792350/
https://ncbi.nlm.nih.gov/pubmed/33413614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-02086-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars